Medtronic won the EU CE Mark for its MiniMed 780G closed loop insulin pump that features both Medtronic’s own SmartGuard algorithm and MD-Logic, an algorithm developed by DreaMed Diabetes, a small Israeli firm. The system, indicated to be used by patients with type 1 diabetes between ages 7 and 80, automatically delivers both basal insulin and correcting boluses every five minutes, if necessary.

Read more here.